Science
More in Science
Why scientists are studying if chloroquine could treat coronavirus
Bill Sullivan takes a close look at why this old malaria drug could be promising for COVID-19.
Creating a molecular map for the plant sciences
Bernhard Kuster of the Technical University of Munich writes about how his lab created the first comprehensive map of the proteome of the model plant Arabidopsis thaliana.
From the journals: JBC
Flu-fighting fat, prevention of chemotherapy pain and activation of anti-aging enzymes. Read about recent papers on these topics and more in the Journal of Biological Chemistry.
Finding novel drug targets in tuberculosis
Researchers report a novel mechanism of controlling synthesis of the essential vitamin K<sub>2</sub> in the bacterial pathogen that causes tuberculosis.
Removing belly fat before it sticks to you
Researchers at the University of Cincinnati College of Medicine have found a way to produce in the laboratory a human protein that plays an important role in metabolizing and clearing excess levels of triglycerides from the bloodstream.
This disease kills half the people it infects. So why isn’t more being done?
Melioidosis is a bacterial infection that quietly causes thousands of deaths each year. Meet the doctor who made it his mission to make the world take notice.
Parkinson's Awareness Month
More in Science
The bee microbiome can fight back against fungi that cause Colony Collapse Disorder
Biocontrol may help bees where other interventions, like chemical pesticides, have failed.
How spider venom could help relieve pain
Does the key to safe, effective pain treatments lie in modified tarantula venom? A recent JBC article from Janssen Research and Development offers an answer.
The best of two worlds
Cecil Pickett’s research career spanned several decades and led to pivotal findings on oxidative stress responses and key breakthroughs in drug discovery.
'We are doers. We want to get involved.'
In a department that feels almost deserted, basic scientists join the COVID-19 effort.
From the journals: MCP
New therapeutic targets for hyperactive mTOR, a SPEEDy way to prepare mass spec samples, and a new program to identify and validate citrullinated peptides. Read about these recent papers in the journal Molecular & Cellular Proteomics.
What makes remdesivir a promising antiviral?
Clinical trials around the world are testing remdesivir, a nucleotide analog, for possible effects against the novel coronavirus. We asked some experts what makes the molecule interesting.
Join the ASBMB Today mailing list
Sign up to get updates on articles, interviews and events.